ITK deficiency protects against autoimmune pulmonary hemorrhage by promoting Amphiregulin producing regulatory T cells

ITK deficiency nearly completely prevents autoimmune pulmonary hemorrhage by enhancing regulatory T cell function in a mouse model.

• Why it matters: Understanding molecular checkpoints that shift immune responses from damaging inflammation to tissue repair is crucial for treating severe autoimmune lung diseases with high mortality rates.
• What they did: Using a pristane-induced pulmonary hemorrhage model, researchers showed that ITK deficiency leads to expansion of Foxp3+ Tregs, reprograms them toward a metabolically active state, and that adoptive transfer of ITK-deficient Tregs rescues PH and reduces systemic inflammation.
• The result: These findings suggest targeting ITK could promote protective immune regulation and tissue repair in inflammatory lung conditions, offering a mechanistic basis for new therapies.